Correlation Between Aelis Farma and Transgene

Can any of the company-specific risk be diversified away by investing in both Aelis Farma and Transgene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aelis Farma and Transgene into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Aelis Farma SA and Transgene SA, you can compare the effects of market volatilities on Aelis Farma and Transgene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aelis Farma with a short position of Transgene. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aelis Farma and Transgene.

Diversification Opportunities for Aelis Farma and Transgene

0.82

Correlation Coefficient

Aelis Farma  Transgene

Very poor diversification

The 3 months correlation between Aelis and Transgene is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding Aelis Farma SA and Transgene SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Transgene SA and Aelis Farma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aelis Farma SA are associated (or correlated) with Transgene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Transgene SA has no effect on the direction of Aelis Farma i.e., Aelis Farma and Transgene go up and down completely randomly.

Pair Corralation between Aelis Farma and Transgene

Assuming the 90 days trading horizon Aelis Farma SA is expected to under-perform the Transgene. But the stock apears to be less risky and, when comparing its historical volatility, Aelis Farma SA is 1.07 times less risky than Transgene. The stock trades about -0.44 of its potential returns per unit of risk. The Transgene SA is currently generating about -0.15 of returns per unit of risk over similar time horizon. If you would invest  104.00  in Transgene SA on September 17, 2024 and sell it today you would lose (31.00) from holding Transgene SA or give up 29.81% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Aelis Farma SA  vs.  Transgene SA

Aelis Farma SA

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Aelis Farma SA has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Transgene SA

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Transgene SA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's technical and fundamental indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Aelis Farma and Transgene

The main advantage of trading using opposite Aelis Farma and Transgene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aelis Farma position performs unexpectedly, Transgene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Transgene will offset losses from the drop in Transgene's long position.

The idea behind Aelis Farma SA and Transgene SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.